chr13-77895737-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_001122659.3(EDNRB):c.*2463T>C variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.0032 in 152,158 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0032 ( 6 hom., cov: 32)
Failed GnomAD Quality Control
Consequence
EDNRB
NM_001122659.3 3_prime_UTR
NM_001122659.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.18
Genes affected
EDNRB (HGNC:3180): (endothelin receptor type B) The protein encoded by this gene is a G protein-coupled receptor which activates a phosphatidylinositol-calcium second messenger system. Its ligand, endothelin, consists of a family of three potent vasoactive peptides: ET1, ET2, and ET3. Studies suggest that the multigenic disorder, Hirschsprung disease type 2, is due to mutations in the endothelin receptor type B gene. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.0032 (487/152158) while in subpopulation AMR AF= 0.00413 (63/15266). AF 95% confidence interval is 0.00331. There are 6 homozygotes in gnomad4. There are 225 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 6 SD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EDNRB | NM_001122659.3 | c.*2463T>C | 3_prime_UTR_variant | 7/7 | ENST00000646607.2 | NP_001116131.1 | ||
EDNRB-AS1 | NR_103853.1 | n.1695-11955A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EDNRB | ENST00000646607.2 | c.*2463T>C | 3_prime_UTR_variant | 7/7 | NM_001122659.3 | ENSP00000493527 | P1 | |||
EDNRB | ENST00000377211.8 | c.*2463T>C | 3_prime_UTR_variant | 8/8 | 1 | ENSP00000366416 | ||||
EDNRB | ENST00000646605.1 | c.*2463T>C | 3_prime_UTR_variant | 8/8 | ENSP00000494278 | P1 | ||||
EDNRB | ENST00000646948.1 | c.*2463T>C | 3_prime_UTR_variant | 8/8 | ENSP00000493895 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00322 AC: 490AN: 152040Hom.: 6 Cov.: 32
GnomAD3 genomes
AF:
AC:
490
AN:
152040
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0AC: 0AN: 0Hom.: 0 Cov.: 0AC XY: 0AN XY: 0
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
Cov.:
0
AC XY:
0
AN XY:
0
GnomAD4 genome AF: 0.00320 AC: 487AN: 152158Hom.: 6 Cov.: 32 AF XY: 0.00302 AC XY: 225AN XY: 74382
GnomAD4 genome
AF:
AC:
487
AN:
152158
Hom.:
Cov.:
32
AF XY:
AC XY:
225
AN XY:
74382
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
11
AN:
3462
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hirschsprung disease, susceptibility to, 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at